Shattuck Labs (STTK) Research & Development (2019 - 2026)
Shattuck Labs (STTK) reported Research & Development of $10.9 million for Q1 2026, up 10.35% year-over-year from $9.9 million in Q1 2025, and up 20.88% quarter-over-quarter from $9.1 million in Q4 2025.
Shattuck Labs (STTK) Research & Development (2019 - 2026) Analysis & Trends
Shattuck Labs (STTK) has 8 years of Research & Development data on file, last reported at $10.9 million in Q1 2026.
- Research & Development for Q1 2026 came in at $10.9 million, up 10.35% year-over-year; the trailing twelve-month figure through Mar 2026 was $36.3 million (down 40.36% YoY), and the FY2025 annual result was $35.3 million, down 47.52% from the prior year.
- Research & Development improved to $10.9 million in Q1 2026 per STTK's latest filing, from $9.1 million in the prior quarter.
- Over five years, Research & Development peaked at $24.2 million in Q3 2023 and troughed at $7.6 million in Q3 2025.
- A 5-year average of $15.9 million and a median of $16.3 million in 2024 frame the typical range for Research & Development.
- The sharpest annual moves came in 2022 and 2025: Research & Development jumped 85.61% in 2022, then slumped 54.88% in 2025.
- A 5-year view of Research & Development shows it stood at $21.9 million in 2022, then plunged by 30.43% to $15.2 million in 2023, then increased by 1.1% to $15.4 million in 2024, then plunged by 41.18% to $9.1 million in 2025, then increased by 20.88% to $10.9 million in 2026.
- Business Quant data shows STTK's Research & Development at $10.9 million in Q1 2026, $9.1 million in Q4 2025, and $7.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 4.32 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 15.66 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 626,092.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -101.30 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -2.30 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 1.46 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 357,444.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 961.60 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -58.00 Mn |
| 10 | Shattuck Labs | 190.32 Mn | 190.32 Mn | - | 10.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.95 Mn |
| Dec 31, 2025 | 9.06 Mn |
| Sep 30, 2025 | 7.62 Mn |
| Jun 30, 2025 | 8.68 Mn |
| Mar 31, 2025 | 9.92 Mn |
| Dec 31, 2024 | 15.40 Mn |
| Sep 30, 2024 | 16.31 Mn |
| Jun 30, 2024 | 19.24 Mn |
| Mar 31, 2024 | 16.26 Mn |
| Dec 31, 2023 | 15.23 Mn |
| Sep 30, 2023 | 24.21 Mn |
| Jun 30, 2023 | 18.21 Mn |
| Mar 31, 2023 | 16.67 Mn |
| Dec 31, 2022 | 21.89 Mn |
| Sep 30, 2022 | 18.86 Mn |
| Jun 30, 2022 | 22.96 Mn |
| Mar 31, 2022 | 19.19 Mn |
| Dec 31, 2021 | 16.21 Mn |
| Sep 30, 2021 | 15.14 Mn |
| Jun 30, 2021 | 14.88 Mn |